Gossamer Bio is set to report the results of its Phase 3 clinical trial focused on pulmonary arterial hypertension (PAH), a progressive lung disease, by the...
Gossamer Bio is preparing to announce the results of its Phase 3 clinical trial focused on treating pulmonary arterial hypertension, a serious and progressive lung disease....
